1
TITLE: Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder
AUTHORS: Zastrozhin, MS; Skryabin, VY; Petukhov, AE; Torrado, MV; Pankratenko, EP; Zastrozhina, AK; Grishina, EA; Ryzhikova, KA; Shipitsyn, VV; Bryun, EA; Sychev, DA;
PUBLISHED: 2021, SOURCE: PHARMACOGENOMICS JOURNAL
INDEXED IN: Scopus WOS
2
TITLE: Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder
AUTHORS: Michael S Zastrozhin; Valentin Y Skryabin; Marco Torrado; Anastasiya Petrovna; Alexander S Sorokin; Elena A Grishina; Kristina A Ryzhikova; Inessa A Bedina; Oleg Z Buzik; Egor M Chumakov; Ludmila M Savchenko; Evgeny A Brun; Dmitry A Sychev;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS, VOLUME: 21, ISSUE: 2
INDEXED IN: Scopus WOS
3
TITLE: Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome
AUTHORS: Valentin Yurievich Skryabin; Mikhail Zastrozhin; Marco Torrado; Elena Grishina; Kristina Ryzhikova; Valery Shipitsyn; Tatiana Galaktionova; Alexander Sorokin; Evgeny Bryun; Dmitry Sychev;
PUBLISHED: 2020, SOURCE: HOSPITAL PHARMACY
INDEXED IN: Scopus WOS